Watson Pays $27M To Exit Drug Inflation MDL

Law360, New York (December 13, 2011, 10:11 PM EST) -- Watson Pharmaceuticals Inc. on Tuesday agreed to pay $27 million to settle the remaining whistleblower claims against it in the Massachusetts multidistrict litigation accusing several pharmaceutical companies of reporting inflated drug prices to Medicaid.

In a joint motion to approve the settlement, Watson and relator Ven-A-Care of the Florida Keys Inc. also asked U.S. District Judge Patti B. Saris to dismiss all remaining claims with prejudice.

The parties had previously resolved portions of the federal qui tam proceedings relating to medicaid payments by states including Texas...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.